Trial intelligence / Profile preview

Nadroparin accumulation in renal insufficiency assessed by anti-Xa levels

2011-002128-41Phase 4Active

Sponsor
Erasmus MC
Start
Jun 2011
Modality
Small Molecules, Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 4 trial of nadroparin in venous thromboembolism (VTE), sponsored by Erasmus MC. Started Jun 2011; status: active.

02

Drugs

nadroparin
03

Conditions

venous thromboembolism (VTE)

Beyond the preview

Go deeper on 2011-002128-41.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-002128-41.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call